Status:
COMPLETED
Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Covid19
Eligibility:
All Genders
3-72 years
Phase:
NA
Brief Summary
The purpose of this study is to understand how to prevent COVID-19 spread in a school like the Mary Cariola Center (MCC) in Rochester, NY by answering questions like these: how do activities in the sc...
Eligibility Criteria
Inclusion
- Students:
- IDD Student of the Mary Cariola Center
- Age 3 - 18
- Have a parent/guardian who can give informed consent
- In the judgement of the Mary Cariola Medical Staff will be able to safely participate in the study procedures (nasal swab, phlebotomy)
- Staff
- Age 18 - 72
- Able give informed consent
- Anticipated duration of remaining employment less than 1 month (e.g. retiring)
- Must be willing to participate in RT-PCR and antibody testing
Exclusion
- Students
- Contraindication to nasal swab
- Contraindication to phlebotomy (e.g. anticoagulated, bleeding diathesis)
- Staff
- Contraindication to nasal swab
- Contraindication to phlebotomy (e.g. anticoagulated, bleeding diathesis)
Key Trial Info
Start Date :
May 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
392 Patients enrolled
Trial Details
Trial ID
NCT04887129
Start Date
May 3 2021
End Date
March 31 2024
Last Update
February 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mary Cariola Center
Rochester, New York, United States, 14620